It has become apparent during the past two decades that the vital functions of eukaryotic cells are intimately associated with the synthesis of the polyamines, spermidine and spermine (Pegg & McCann, 1982) . Many studies using either whole animals or cell cultures have shown marked increases in ornithine decarboxylase (EC 4.1.1.17) in growing organs and tissues which leads to the formation of putrescine, a key step in the eukaryotic pathway of polyamine biosynthesis. Spermidine is formed from putrescine by the addition of an aminopropyl group derived from decarboxylated S-adenosylmethionine and the transfer of a second aminopropyl group converts spermidine to spermine. These reactions are dependent on another important enzyme of polyamine metabolism, S-adenosylmethionine decarboxylase (EC 4.1.1.50). Cellular levels of putrescine, spermidine and spermine increase sequentially during the cell cycle with biphasic peaks, firstly during the early Sphase of DNA synthesis and, later, before cell division. The essential nature of such increases for the maintenance of these cellular events has been demonstrated convincingly with the recent availability of specific inhibitors of polyamine biosynthesis. Both DFMO, a catalytically activated inhibitor of ornithine decarboxylase, and MGBG, a reversible inhibitor of S-adenosylmethionine decarboxylase, can inhibit cellular D N A replication and, ultimately, block cell division. These inhibitors have also been used to show that polyamines can play a further r6le in the differentiation of mammalian cells but, as with cell mitosis, the physiological significance of spermidine and spermine is poorly understood in molecular terms.
Viruses are obligate intracellular parasites consisting of nucleic acid enclosed within a protective protein coat. Since virus particles are metabolically inert they are absolutely dependent on the host cell for their replication. Thus, the production of virus-specific nucleic acid and protein directed by the infective genome should be subject to the same physiological constraints on macromolecular synthesis found in uninfected cells. By the application of appropriate biochemical techniques it should be possible to correlate molecular events in the virus growth cycle with quantitative and/or qualitative changes in polyamine metabolism in the infected cells. Although further extrapolations must be made cautiously, such information may point also to the molecular rdes of polyamines in cellular biology. This proposition has been investigated by using vaccinia virus replication as a model system.
Ornithine decarboxylase activity in HeLa cells increases markedly after infection with vaccinia virus to reach a peak at about 5 h post-infection before returning to undetectable levels by 9 h post-infection (Hodgson & Williamson, 1975) . This temporal pattern of enzyme induction is remarkable for two reasons: host protein synthesis in HeLa cells is inhibited rapidly after vaccinia infection, reaching minimum levels by 5 h post-infection, and ornithine decarboxylase in mammalian cells has a very short half-life. It is possible, therefore, that ornithine decarboxylase activity in vaccinia-infected HeLa cells is determined by a virusspecified enzyme. The genome of vaccinia virus is known to encode a number of enzymes required for virus DNA Abbreviations used : DFMO, DL-a-difluoromethylornithine; MGBG, methylglyoxal bis(guany1hydrazone); CMV, cytomegalovirus; AIDS, acquired immune deficiency syndrome. Vol. 13 synthesis, which are distinguishable from host cell enzymes by physicochemical criteria. The K,,, value of ornithine ctecatrboftylase was found fo be 0.12 x M from uninfected cells but 0.05 x 1 0 -3~ for the enzyme from vacciniainfected cells. Other virus-coded enzymes such as thymidine kinase or DNA polymerase are also characterized by their temporal control during vaccinia virus replication because their activity is expressed shortly after infection but diminishes rapidly as virus DNA synthesis proceeds. Since this switch-off mechanism is affected by the synthesis of viral DNA, the activity of these early virus-coded enzymes can continue undiminished in vaccinia-infected cells exposed to inhibitors of DNA synthesis. Such treatment of HeLa cells infected with vaccinia virus resulted in the prolonged expression of ornithine decarboxylase at times when the enzyme activity had returned to basal levels in control infected cells and in uninfected HeLa cells maintained in the presence of the inhibitor (Hodgson & Williamson, 1975) . These properties argue strongly that ornithine decarboxylase is encoded in the vaccinia virus genome and, in view of the stringent economy of viral genetic information, it appears that polyamine biosynthesis is essential during vaccinia virus replication. This conclusion is supported by the further demonstration of Sadenosylmethionine decarboxylase activity in vacciniainfected HeLa cells (Hodgson, 1976) .
The growth of vaccinia virus is inhibited by the withdrawal of arginine from the medium supplied to infected cultures. Although the amino acid is required for the synthesis of viral proteins containing arginyl residues, the formation of ornithine by the action of arginase may be regarded as the initial step for polyamine biosynthesis in mammalian cells. By using KB cell cultures as the host system, early events in the virus replication cycle proceed up to vaccinia DNA synthesis but arginine deprivation inhibits further events leading to the transcription of late virus-specific mRNA. However, this requirement for arginine can be replaced by ornithine, putrescine, spermidine or spermine (Obert et al., 1980 ). These studies also demonstrated a further need for polyamines in the morphogenesis of vaccinia virions. Immature particles were seen by electron microscopy in sections from vacciniainfected KB cells without arginine but the addition of ornithine or polyamines to such cultures permitted the condensation of electron-dense material, an event leading to the formation of the DNA-containing nucleoid in mature virions. These requirements have their counterparts in cellular biology but they have mainly been inferred from studies with systems in uitro. Polyamines bind to nucleic acids giving rise to conformational changes and to enhanced activity of various enzymes associated with nucleic acid replication, transcription and translation (Janne et al., 1978) .
More definitive proof for the essential nature of polyamines in vaccinia virus replication has been obtained from the use of specific enzyme inhibitors (Tyms et al., 1983) . MGBG inhibits the production of infectious progeny virus in HeLa cells with a median value (ED,,) of 3 3 0~~ calculated from the dose-response curves, but repeated passage in the presence of ~O O~M -M G B G selected a virus population resistant to the compound. However, DFMO inhibited the growth of both virus populations with an EDso value of 5 . 9 m~, showing no indication of a drug-resistant population with this inhibitor.
Recognition of the anti-viral effect of polyamine inhibitors against vaccinia virus replication has led to further investigations with more important human pathogens. Human CMV, a member of the herpesvirus family, is the most common infectious cause of congenital disease and a serious complication in immunocompromised hosts. Quantitative analysis of polyamine biosynthesis in human diploid fibroblasts (MRC-5 cells) infected with human CMV showed that the intracellular levels of spermidlne and spermine were 1.5-and 12.4-fold hi her, respectively, than requirement for continued polyamine biosynthesis during human CMV replication was demonstrated by the antiviral effects of, MGBG and DFMO using plaque reduction methods. An ED,, value of 0 . 6~~ for MGBG compares with values of 33.5 PM for 9-(2-hydroxyethoxymethyl)-guanine and 5.3 PM for 5-iodo-2'-deoxyuridine : both nucleoside analogues have been used clinically for the treatment of human CMV infections. Although MGBG has additional effects on cell functions other than polyamine metabolism, the anti-viral effect is not due to indiscriminate toxic action on the host cells since vaccinia virus is able' to replicate in MRC-5 cells treated with MGBG at concentrations which completely inhibit human CMV replication (Tyms et al., 1983) . Because DFMO is catalytically activated by ornithine decarboxylase to irreversibly inhibit the enzyme, this unique action confers high specificity. There was a marked reduction in the amount of infective virus produced in MRC-5 cells treated with IOmM-DFMO that was accompanied by a complete inhibition of the formation of intranuclear inclusions, which are the sites of virus-specific DNA synthesis in human CMV-infected cells (Tyms & Williamson, 1982) . The anti-viral effect of DFMO against human CMV replication has been confirmed in a recent study with human foreskin fibroblast cells but their exposure to the drug for 3 days before infection was required to obtain the maximum reduction in virus yield and postreplicative events in the virus-replication cycle appeared to be affected (Gibson et al., 1984) . Pretreatment with DFMO or MGBG is also necessary to inhibit herpes simplex virus replication (Tuomi et al., 1980; Tyms et al., 1983) . Both inhibitors of polyamine metabolism have recently been used in uninfected control cells (Tyms & 8, illiamson, 1982 Sjoerdsma & Schechter, 1984) .
Finally, polyamines may be significant aetiological factors in the pathogenesis of certain infectious diseases.
Acetylated diamines and spermidine or spermine as free bases are known to inhibit assays of lymphocyte function in vitro. Similar immunosuppressive mechanisms in viuo can be postulated to occur in AIDS through the presence of spermine at high concentrations in human seminal plasma.
Since human CMV infections occur frequently in AIDS patients, the changes in polyamine metabolism induced by this virus may exacerbate the pathological processes of the disease (Williamson, 1984) .
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